Xponance, Inc. Vista Gen Therapeutics, Inc. Transaction History

Xponance, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 23, 2023	BUY	$0.09 - $4.8 $66 - $3,542	738 Added 6.93%	11,394 $0
Q3 2022 Oct 24, 2022	BUY	$0.14 - $4.8 $14 - $499	104 Added 0.99%	10,656 $2,000
Q2 2022 Aug 02, 2022	BUY	$0.88 - $1.73 $9,285 - $18,254	10,552 New	10,552 $9,000
Q3 2021 Nov 05, 2021	SELL	$2.62 - $3.45 $27,439 - $36,131	-10,473 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$1.96 - $3.15 $20,527 - $32,989	10,473 New	10,473 $33,000

2.7M

Ticker VTGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 206,836,000
Market Cap $610M
Description
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...

Get notified when there are updates to the investment portfolio of Xponance, Inc., based on Form 13F filings with the SEC.

Stay updated on Xponance, Inc. with notifications on news.